πŸ‡ΊπŸ‡Έ FDA
Patent

US 11702480

Engineered antibodies and uses thereof

granted A61KA61K31/713

Quick answer

US patent 11702480 (Engineered antibodies and uses thereof) held by The Regents of the University of California expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/713